NCT03838731View on ClinicalTrials.gov

Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

December 21, 2019

Study Completion Date

April 6, 2020

Conditions
Cat AllergyMild Asthma
Interventions
DRUG

REGN1908-1909

Single subcutaneous (SC) dose of REGN1908 and REGN1909

DRUG

Placebo

Single subcutaneous (SC) dose of matching placebo

Trial Locations (1)

67000

Regeneron Research Site, Strasbourg

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT03838731 - Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge | Biotech Hunter | Biotech Hunter